| NRXP Stock | | | USD 2.27 0.02 0.87% |
NRX Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating NRX Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NRX Pharmaceuticals is a good investment. Please check the relationship between NRX Pharmaceuticals Tax Provision and its Ebitda accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRX Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in interest.
To learn how to invest in NRX Stock, please use our
How to Invest in NRX Pharmaceuticals guide.
Tax Provision vs Ebitda
Tax Provision vs Ebitda Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
NRX Pharmaceuticals Tax Provision account and
Ebitda. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between NRX Pharmaceuticals' Tax Provision and Ebitda is 0.41. Overlapping area represents the amount of variation of Tax Provision that can explain the historical movement of Ebitda in the same time period over historical financial statements of NRX Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of NRX Pharmaceuticals' Tax Provision and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Tax Provision of NRX Pharmaceuticals are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Tax Provision i.e., NRX Pharmaceuticals' Tax Provision and Ebitda go up and down completely randomly.
Correlation Coefficient | 0.41 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.
Ebitda
Most indicators from NRX Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NRX Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NRX Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in interest.
To learn how to invest in NRX Stock, please use our
How to Invest in NRX Pharmaceuticals guide.At this time, NRX Pharmaceuticals'
Selling General Administrative is relatively stable compared to the past year. As of 03/01/2025,
Issuance Of Capital Stock is likely to grow to about 19.7
M, though
Enterprise Value Over EBITDA is likely to grow to
(1.12).
NRX Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
NRX Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
NRX Pharmaceuticals fundamental ratios Accounts
Additional Tools for NRX Stock Analysis
When running NRX Pharmaceuticals' price analysis, check to
measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.